SMAD2 and Hepatic fibrosis: Evidences have shown that TGF-β1/Smad2/3 signaling play a pro-fibrotic role, while IFN-γ/STAT1/Smad7 signaling pathway exhibit an anti-fibrotic role in liver fibrosis progression [32,33].